C

Cencora

Distributes medicines and supports patient care

Senior Program Manager

Full-TimeUpdated on 10/22/2026
$119.1k - $186.6k
Senior, Expert
Bachelor's
Remote in USA
Remote
Project & Program ManagementProgram Management

About the job

Requirements
  • A bachelor's degree is required.
  • At least 8 years of program or project management experience, including leadership of complex, cross-functional initiatives.
  • Experience leading a major workstream within a large enterprise-wide transformation, ERP transformation, or similarly complex strategic program.
  • Strong experience in integrated planning, risk management, issue resolution, and stakeholder coordination.
  • Experience working across business and technology teams in a matrixed environment.
  • Deep expertise in large-scale program budget management.
  • Demonstrated ability to manage complexity, drive execution, and influence without direct authority.
  • Strong written, verbal, and executive-level communication skills.
Responsibilities
  • Lead an assigned workstream within the broader enterprise-wide transformation program.
  • Own day-to-day planning, coordination, execution oversight, and delivery tracking for the workstream.
  • Ensure workstream objectives, milestones, deliverables, and dependencies are clearly defined and actively managed.
  • Drive accountability across team members and stakeholders to achieve committed outcomes.
  • Develop and maintain detailed workstream plans, timelines, milestones, and action logs.
  • Coordinate activities across business, IT, functional teams, and external implementation partners.
  • Monitor progress against plan and proactively identify risks, issues, and delivery gaps.
  • Drive timely resolution of blockers and escalate matters as appropriate.
  • Identify, track, and manage workstream risks, issues, assumptions, and dependencies.
  • Partner with other workstream leads to address cross-functional impacts and integration points.
  • Escalate critical risks and decisions to the Program Lead with recommended actions.
  • Prepare and provide regular status updates on workstream progress, milestones, risks, issues, and decisions.
  • Support program governance forums by ensuring timely, accurate, and transparent reporting.
  • Maintain documentation, decision logs, action items, and key workstream artifacts.
  • Build strong relationships with business, IT, and functional stakeholders across the assigned workstream.
  • Partner with implementation teams and vendors to align on scope, deliverables, and timelines.
  • Facilitate discussions, drive alignment, and support decision-making across stakeholders.
  • Partner with business leads and change partners to support readiness, process alignment, and adoption activities.
  • Help ensure the workstream is operationally ready for implementation as well as technically delivered.
  • Reinforce focus on business outcomes, user impact, and sustainable adoption.
  • Drive disciplined execution, issue resolution, and follow-through across the workstream.
  • Ensure alignment with overall program governance, standards, templates, and reporting expectations.
  • Support integrated planning and coordination with the broader transformation office and program leadership team.
  • Lead workstream budget management, including actuals, forecast, accruals, and variance analysis.
  • Partner with Finance and PMO to maintain accurate financial reporting and forecast updates aligned to scope, resources, and delivery plans.
  • Drive disciplined, repeatable financial management processes aligned with program governance and financial best practices.
  • Identify, communicate, and help mitigate budget risks, forecast changes, and cost impacts across the workstream.
  • Ensure financial controls and documentation are audit-ready and able to withstand internal and external audit scrutiny.
Desired Qualifications
  • Experience with large-scale ERP or enterprise transformation programs.
  • Experience working with system integrators and third-party implementation partners.
  • Familiarity with change management, business readiness, and adoption planning.
  • PMP, Agile, or related certifications are preferred.
  • Experience in complex, highly regulated, or global environments is a plus.

About the company

Cencora buys and distributes medicines for pharmacies, hospitals and physician practices, while helping drug manufacturers bring treatments to patients. Its businesses combine wholesale supply networks with specialty distribution for complex therapies and services that support prescribing and patient access. Customers order medicines through its distribution systems, and its teams manage sourcing, storage and delivery alongside pharmacy operations and manufacturer support. It earns revenue from pharmaceutical sales and fees for logistics and healthcare services. The parent company was formed in 2001 through the merger that created AmerisourceBergen, adopted the Cencora name in 2023, and is headquartered in Conshohocken, Pennsylvania.

Company Size

10,001+

Company Stage

IPO

Headquarters

Conshohocken, Pennsylvania

Founded

2001

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pharmacy contracts deepen customer ties: Cencora negotiates insurer agreements and handles administrative work through its managed-care networks.
  • Eligible US staff gain retirement support: Cencora counts student-loan payments toward its employer match, up to 4% of pay.
  • Drug demand expands sales: Cencora reported 5.1% quarterly revenue growth in August 2026, led by higher US volumes.

What critics are saying

  • Customer dependence concentrates risk: Walgreens and Boots supplied 25% of Cencora's fiscal 2025 revenue, reported in November 2025.
  • Legal liabilities tie up cash: Cencora's November 2025 filing recorded $4.3 billion in opioid settlements, payable over 13 years.
  • Warehouse work is physical: Cencora's day-shift associate listing requires repeated lifting up to 50 pounds and overtime availability.

What makes Cencora unique

  • Independent pharmacies get a shared brand: Cencora's Good Neighbor Pharmacy franchise supports their merchandising and store identity.
  • Specialty shipments use reusable packaging: Cencora's World Courier Cocoon containers combine passive temperature control with live location monitoring.
  • Medicines arrive ready for bedside checks: Cencora's American Health Packaging sells barcoded unit doses that support hospital scanning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Parental Leave
  • Adoption Assistance
  • Infertility Coverage
  • Family Planning Benefits
  • Behavioral Health Solutions
  • Professional Development Budget
  • Training Programs

Company News

Financial News
Oct 21st, 2026
Cencora to buy American Oncology Network in $2.4bn deal

Cencora agrees to buy American Oncology Network for $2.4bn enterprise value, but a stockholder rollover means it may land only 75% of the company.

Yahoo Finance
Oct 16th, 2026
Cencora stock: $332.8B revenue, 14.4% EPS growth and 50.2% ROIC

Cencora, the pharmaceutical distributor formerly known as AmerisourceBergen, has risen 6% to $341.69 per share over the past six months. The S&P 500 gained 9.7% in the same period. The New York Stock Exchange-listed company (NYSE:COR) connects drug manufacturers with healthcare providers and offers logistics, data analytics, and consulting services. It rebranded in 2023. Its revenue reached $332.8 billion over the past 12 months, giving it scale and bargaining power with suppliers. That matters in a low-margin, volume-driven business. Earnings per share grew at a 14.4% compound annual rate over five years, outpacing 10.2% annualised revenue growth. Its five-year average return on invested capital was 50.2%. The shares trade at 17.4 times forward earnings.

Associated Press
Sep 2nd, 2026
Cencora launches cell and gene therapy service to help health systems scale advanced treatment programmes

Cencora has launched Cell and Gene Therapy Enablement through its Accelerate Pharmacy Solutions division to help health systems develop and expand cell and gene therapy programmes. The service provides support across financial planning, operational readiness, and scalable growth to reduce care barriers and improve patient access to advanced therapies. More than 35 cell and gene therapies have received FDA approval, with over 1,700 clinical trials underway globally. However, only 4% of health system pharmacy leaders report being fully prepared to integrate these treatments, highlighting infrastructure gaps. The offering includes market assessments, readiness evaluations, governance design, and workflow planning. Cencora, ranked number 10 on the Fortune 500 with over $300 billion in annual revenue, already provides specialty pharmaceutical services across the therapy lifecycle.

Yahoo Finance
Aug 14th, 2026
Cencora beats Q2 profit estimates as specialty pharma platform drives growth

Cencora reported second-quarter revenue of $84.75 billion, slightly above analyst estimates of $84.43 billion, representing 5.1% year-on-year growth. Adjusted earnings per share came in at $4.48, beating consensus estimates of $4.35 by 3%. Management attributed the performance to strength in specialty pharmaceuticals, particularly through Management Services Organisations like OneOncology and RCA. CEO Robert Mauch highlighted the company's positioning in specialty care, stating, "Our specialty platform supports growth across the healthcare ecosystem." The company raised its full-year adjusted EPS guidance to $17.85 at the midpoint. Operating margin held steady at 1.3%, matching the same quarter last year. During the earnings call, analysts questioned management about biosimilar opportunities, specialty logistics competition, and potential policy risks from proposed ASP rule changes.

Yahoo Finance
Aug 12th, 2026
Cencora raises FY2026 guidance after Q3 EPS jumps 12%, buys back $1B in shares

Cencora reported strong third-quarter results for fiscal year 2026, driven by execution across its business units and investments in its specialty positioning. The pharmaceutical distributor achieved double-digit adjusted operating income growth and 12% earnings per share growth in the quarter. The company conducted $1 billion in opportunistic share repurchases during the period. Based on its performance and confidence in continued execution, Cencora raised its fiscal 2026 EPS guidance. President and CEO Robert Mauch credited the results to the company's team members and their commitment to providing solutions for customers. He highlighted the strength of Cencora's portfolio and its pharmaceutical-centric strategy as the company approaches the end of its fiscal year. The earnings call was held on 5 August 2026, with senior leadership including Mauch and CFO Eva Boratto participating.